Clinical Trials List
Protocol NumberBMA222207
Completed
2023-07-01 - 2025-12-31
Others
Recruiting3
xxxxxx
-
Trial Applicant
SHINER PHARM CORP.
-
Sponsor
xxxxxx
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
xxxxxx
Objectives
xxxxxx
Test Drug
xxxxxx
Active Ingredient
sodium phenylbutyrate
Dosage Form
110
Dosage
500mg
Endpoints
xxxxxx
Inclution Criteria
xxxxxx
Exclusion Criteria
xxxxxx
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
20 participants
